Patent details
301144
Product Name:
Apalutamide
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
301144
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP3533792
Status:
SPC granted but not yet in force
Application number:
301144
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)
Marketing Authorization
Marketing Authorization Number:
EU/1/18/1342
Marketing Authorization Type:
EEA
Marketing Authorization Date:
16/01/2019
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
03/11/2021
First Marketing Authorization date:
16/01/2019
Grant date:
20/03/2025
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
03/11/2021
SPC/SPC Extension Expiration Date:
15/01/2034
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
12/09/2022
Name:
Aragon Pharmaceuticals, Inc.
Address:
10990 Wilshire Blvd. Suite 440, 90024, Los Angeles, CA, United States of America (US)
From:
03/11/2021
Name:
Sloan Kettering Institute For Cancer Research
Address:
1275 York Avenue, New York, NY 10065, United States of America (US)
Historical Applicant/holder
From:
03/11/2021
To:
12/09/2022
Name:
Aragon Pharmaceuticals, Inc.
Address:
10990 Wilshire Blvd. Suite 300, Los Angeles, CA 90024, United States of America (US)
Agent
1
Name:
ir. B.Ch. Ledeboer c.s
From:
09/01/2025
Address:
V.O.
Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:
2
Name:
ir. H.A. Witmans c.s.
From:
03/11/2021
Address:
V.O.
Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:
09/01/2025
Publication
Bulletin
1
Bulletin Heading:
SPC
Journal edition number:
13/25
Publication date:
26/03/2025
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
2
Bulletin Heading:
SPC
Journal edition number:
45/21
Publication date:
10/11/2021
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Deed
Change of Address
Change Kind/ Decision Type:
Owner
Deed Number:
RC202202288A
Date Registered:
12/09/2022
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. H.A. Witmans c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Changed Pledgee
Name:
Address:
Removed Usufructuary
Name:
Address:
Added Usufructuary
Name:
Address:
Changed Usufructuary
Name:
Address:
Annual Fee
Annual Fee(s) Due Date:
30/06/2033
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date
Document type
Document Description
Number of pages
File Type
20/03/2025
Outgoing Correspondence
Decision grant
2
PDF
/2/4/7/9/3/0800739742/docs/301144_15_648914l504a.pdf
20/03/2025
Certificate
Certificate
1
PDF
/2/4/7/9/3/0800739742/docs/301144_16_spcmedcertificate20250320135432454.pdf
26/02/2025
Incoming Correspondence Electronic
Accompanying letter incoming document
3
PDF
/2/4/7/9/3/0800739742/docs/301144_14_incomingcorrespondenceelectronic20250228034005600.pdf
27/11/2024
Outgoing Correspondence
Letter to applicant
3
PDF
/2/4/7/9/3/0800739742/docs/301144_12_632906l173.pdf
11/11/2024
SPC Documents
Annex SPC
1
PDF
/2/4/7/9/3/0800739742/docs/301144_13_supplprotectioncertificate20241111040033425.pdf
08/06/2022
Outgoing Correspondence
Letter to applicant
1
PDF
/2/4/7/9/3/0800739742/docs/301144_10_483971l173.pdf
30/05/2022
Incoming Correspondence Paper
Accompanying letter incoming document
1
PDF
/2/4/7/9/3/0800739742/docs/301144_11_incomingcorrespondencepaper20220531101804926.pdf
22/02/2022
Outgoing Correspondence
Letter to applicant
2
PDF
/2/4/7/9/3/0800739742/docs/301144_7_463803l173.pdf
21/02/2022
Incoming Correspondence Paper
Accompanying letter incoming document
1
PDF
/2/4/7/9/3/0800739742/docs/301144_6_incomingcorrespondencepaper20220221042242831.pdf
07/12/2021
Outgoing Correspondence
Letter to applicant
3
PDF
/2/4/7/9/3/0800739742/docs/301144_5_448947l173.pdf
04/11/2021
Outgoing Correspondence
Confirmation receipt request
1
PDF
/2/4/7/9/3/0800739742/docs/301144_8_444205l174.pdf
03/11/2021
SPC Documents
Annex SPC
2
PDF
/2/4/7/9/3/0800739742/docs/301144_0_supplprotectioncertificate20211103045055502.pdf
03/11/2021
SPC Documents
Marketing Authorization SPC
3
PDF
/2/4/7/9/3/0800739742/docs/301144_1_supplprotectioncertificate20211103045055403.pdf
03/11/2021
SPC Documents
Annex SPC
28
PDF
/2/4/7/9/3/0800739742/docs/301144_2_supplprotectioncertificate20211103045055481.pdf
03/11/2021
SPC Documents
Annex SPC
3
PDF
/2/4/7/9/3/0800739742/docs/301144_3_supplprotectioncertificate20211103045055461.pdf
03/11/2021
Application Form
First filed application form
3
PDF
/2/4/7/9/3/0800739742/docs/301144_4_applicationform20211103045055346.pdf
03/11/2021
SPC Documents
Summary of the characteristics of the product
14
PDF
/2/4/7/9/3/0800739742/docs/301144_9_supplprotectioncertificate20211103045055429.pdf